Endothelial-dependent dynamic and antithrombotic properties of porcine aortic and pulmonary valves

Annals of Thoracic Surgery

Volumn 65, Issue 4 SUPPL., 1998, Pages 986-992

  Pompilio, Giulio ^a   Rossoni, Giuseppe ^b   Sala, Andrea ^b   Polvani, Gian Luca ^b   Berti, Ferruccio ^b   Dainese, Luca ^b   Porqueddu, Massimo ^b   Biglioli, Paolo ^b  

^a Monzino Foundation   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLCHOLINE; AUTACOID; ENDOTHELIN 1; N(G) METHYLARGININE; NITRIC OXIDE; NORADRENALIN; POTASSIUM CHLORIDE; PROSTACYCLIN;

ANIMAL TISSUE; AORTA VALVE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PULMONARY VALVE; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE; SWINE; THROMBOSIS; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; AORTIC VALVE; AUTACOIDS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EPOPROSTENOL; FIBRINOLYTIC AGENTS; HOMEOSTASIS; MICROSCOPY, ELECTRON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PLATELET AGGREGATION INHIBITORS; PULMONARY VALVE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031953908     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00075-7     Document Type: Article

References (28)

1. Andries LJ, Brutsaert DL. Differences in structure between endocardial and vascular endothelium. J Cardiovasc Pharmacol 1991;17(Suppl 3):243-6.
2. Ku DD, Nelson JM, Caulfield JB, Winn MJ. Release of endothelium-derived relaxing factors from canine cardiac valves. J Cardiovasc Pharmacol 1990;16:212-18.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
4. Busse R, Mülsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993;87(Suppl 5):18-25.
5. Radovki MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:693-6.
6. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
7. Messier RH, Bass BL, Aly HM, et al. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res 1994;57:1-21.
8. Higashidate M, Tamiya K, Beppu T, Imai Y. Regulation of the aortic valve opening. In vivo dynamic measurement of aortic valve orifice area. J Thorac Cardiovasc Surg 1995;110:496-503.
9. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassay of eicosanoids using an acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-3.
10. Pompilio G, Polvani GL, Rossoni G, et al. Effects of warm ischemia on valve endothelium. Ann Thorac Surg 1997;63:656-62.
11. Palmer RMJ, Ashton DS, Moncade S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
12. Busse R, Trogisch G, Bassenge E. The role of endothelium in the control of vascular tone. Basic Res Cardiol 1985;80:475-90.
13. Furlong B, Hendersen AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987;90:687-92.
14. Rees DD, Palmer RMJ, Hodson HF, Moncada S. Specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1986;96:418-24.
15. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989;96:418-24.
16. Marietta MA. Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 1989;14:488-92.
17. Siney L, Lewis MJ. Nitric oxide release from porcine mitral valves. Cardiovasc Res 1993;27:1657-61.
18. Schulz R, Smith JA, Lewis MJ, Moncada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol 1991;104:21-4.
19. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
20. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
21. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-90.
22. Sala A, Rona P, Pompilio G, et al. Prostacyclin production by different human grafts employed in coronary operations. Ann Thorac Surg 1994;57:1147-50.
23. Busse R, Fleming I. The endothelial organ. Current Opin Cardiol 1993;8:719-27.
24. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from artery transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-5.
25. Vane JR, Anggard EE, Botting RM. Regulatory functions of vascular endothelium. N Engl J Med 1990;323:27-36.
26. Berti F, Rossoni G, Biasi G, Buschi A, Mandelli V, Tondo C. Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous vein. Prostaglandins 1990;40:337-50.
27. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
28. O'Brien MF, Stafford EG, Gardner MAH, et al. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-23.